<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320215</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-N/2010/SD-01</org_study_id>
    <secondary_id>2010-A01110-39</secondary_id>
    <nct_id>NCT01320215</nct_id>
  </id_info>
  <brief_title>Complications Associated With Promontofixation for Pelvic Organ Prolapse: Comparing Robot Assisted Laparoscopic and Non-robot Assisted Laparoscopic Surgical Procedures</brief_title>
  <acronym>RoboLaps</acronym>
  <official_title>Complications Associated With Promontofixation for Pelvic Organ Prolapse: a Randomized Trial Comparing Robot Assisted Laparoscopic and Non-robot Assisted Laparoscopic Surgical Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare 30-day complication rates associated with
      promontofixation for pelvic organ prolapse performed via a robot-assisted laparoscopic
      technique versus a non-robot-assisted laparoscopic technique. Secondary objectives include
      comparing technical data, anatomical correction, prolapse recurrence, incontinence, quality
      of life and medico-economic data between the two techniques.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 12, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>presence/absence of complications (composite score)</measure>
    <time_frame>30 days</time_frame>
    <description>The occurrence (in the per-operative phase or within 30 days post-op) of at least one of the following: 1) bleeding complications: hemoperitoneum, blood loss&gt; = 500 ml, transfusion; 2) infectious complications: wound infection, abscess, discitis, mesh infection; 3) any wound caused by a surgeon movement: bladder, digestive, ureteral, or vascular injuries; (4) medical complications: deep vein thrombosis, pulmonary embolism, pneumopathy; 5) trocart sites: infection, hernia; 6) conversion to a laparoscopic or open surgical technique not related to pre-existing adhesions; 7) reintervention; 8) neurological complications: neurological disorders, complications of the central neurological system, sciatica; 9) others: complete urinary retention, lower urinary tract infection, extrusion, erosion of the mesh, hospitalization in intensive care; 10) death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time needed to prep the operation room (min)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay (days)</measure>
    <time_frame>1 month</time_frame>
    <description>The number of days the patient stays in the hospital following promontofixation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time (min)</measure>
    <time_frame>1 day</time_frame>
    <description>The time elapsed between incision and closure of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia time (min)</measure>
    <time_frame>1 day</time_frame>
    <description>The time elapsed between anethesia induction and awakening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Equipment installation time (min)</measure>
    <time_frame>1 day</time_frame>
    <description>Time elapsed between installation of trocarts and insertion of endoscopic instruments (robot arms or coelioscopic tools)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical time (min)</measure>
    <time_frame>1 day</time_frame>
    <description>The time spent manipulating endoscopic intruments or console time for robotic techniques.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of conversion</measure>
    <time_frame>Day 1</time_frame>
    <description>In the robot arm: the need to convert to laparoscopic procedure or open procedure; in the non-robot arm: the need to convert to an open procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of a re-intervention</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of constipation</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of constipation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of constipation</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of constipation</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of fecal incontinence</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of fecal incontinence</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of fecal incontinence</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of fecal incontinence</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of dysparunia</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of dysparunia</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of dysparunia</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence/absence of dysparunia</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP-Q score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP-Q score</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP-Q score</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP-Q score</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam Q max (ml/s)</measure>
    <time_frame>3 months</time_frame>
    <description>Urination rate il ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam Q max (ml/s)</measure>
    <time_frame>12 months</time_frame>
    <description>Urination rate il ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam Q max (ml/s)</measure>
    <time_frame>36 months</time_frame>
    <description>Urination rate il ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam Q max (ml/s)</measure>
    <time_frame>60 months</time_frame>
    <description>Urination rate il ml/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam, volume urinated (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>the volume urinated in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam, volume urinated (ml)</measure>
    <time_frame>12 months</time_frame>
    <description>the volume urinated in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam, volume urinated (ml)</measure>
    <time_frame>36 months</time_frame>
    <description>the volume urinated in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam, volume urinated (ml)</measure>
    <time_frame>60 months</time_frame>
    <description>the volume urinated in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: post-mictionnel residu (ml)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: post-mictionnel residu (ml)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: post-mictionnel residu (ml)</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: post-mictionnel residu (ml)</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: fonctional bladder capacity (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>bladder capacity in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: fonctional bladder capacity (ml)</measure>
    <time_frame>12 months</time_frame>
    <description>bladder capacity in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: fonctional bladder capacity (ml)</measure>
    <time_frame>36 months</time_frame>
    <description>bladder capacity in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: fonctional bladder capacity (ml)</measure>
    <time_frame>60 months</time_frame>
    <description>bladder capacity in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: urethral closure pressure (cm water)</measure>
    <time_frame>3 months</time_frame>
    <description>urethral closure pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: urethral closure pressure (cm water)</measure>
    <time_frame>12 months</time_frame>
    <description>urethral closure pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: urethral closure pressure (cm water)</measure>
    <time_frame>36 months</time_frame>
    <description>urethral closure pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urodynamic exam: urethral closure pressure (cm water)</measure>
    <time_frame>60 months</time_frame>
    <description>urethral closure pressure in cm of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wexner anal incontinence score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wexner anal incontinence score</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wexner anal incontinence score</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wexner anal incontinence score</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODS constipation score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODS constipation score</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODS constipation score</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODS constipation score</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>day 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Day 4</time_frame>
    <description>Is the patient very satisfied, satisfied, somewhat unsatisfied, or very unsatisfied in relation to the procedure?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>3 months</time_frame>
    <description>Is the patient very satisfied, satisfied, somewhat unsatisfied, or very unsatisfied in relation to the procedure?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>12 months</time_frame>
    <description>Is the patient very satisfied, satisfied, somewhat unsatisfied, or very unsatisfied in relation to the procedure?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>36 months</time_frame>
    <description>Is the patient very satisfied, satisfied, somewhat unsatisfied, or very unsatisfied in relation to the procedure?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>60 months</time_frame>
    <description>Is the patient very satisfied, satisfied, somewhat unsatisfied, or very unsatisfied in relation to the procedure?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFDI-20</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFDI-20</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFDI-20</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFDI-20</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFIQ-7</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFIQ-7</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFIQ-7</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PFIQ-7</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PISQ-12</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PISQ-12</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PISQ-12</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire PISQ-12</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF36</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF36</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF36</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF36</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">364</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Robot arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in this arm will have a robot-assisted promontofixation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-robot arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this arm with have a promotofixation via a laparoscopy, but without robot assistance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robot-assisted promontofixation</intervention_name>
    <description>Sacrohysteropexy with robotic assistance (da Vinci robot)</description>
    <arm_group_label>Robot arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-robot assisted promontofixation</intervention_name>
    <description>Laparoscopic sacrohysteropexy, without robot assistance</description>
    <arm_group_label>Non-robot arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has a first,(primo-event), symptomatic, genito-urinary prolapse of at least
             stage II (POP-Q classification) requiring surgery

          -  The patient must have given her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 60 months of follow-up

        Exclusion Criteria:

          -  The patient is participating in another study

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient refuses to sign the consent

          -  It is impossible to correctly inform the patient

          -  The patient is pregnant

          -  Patient has a stage-1 prolapse (POP-Q classification)

          -  Patient has asymptomatic prolapse

          -  The patient has a prolapse recurrence (i.e. this is not the first case of prolapse)

          -  The patient is not available for 60 months of follow-up

          -  Patient has a vaginal or urinary infection

          -  Patient has poorly-adjusted diabetes

          -  Patient on long-term corticotherapy

          -  Patient has previously had pelvic radiotherapy

          -  Patient has contraindication for anesthesia

          -  Patient has an intestinal inflammatory disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Droupy, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes</city>
        <state>Gard</state>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Urologie Saint Augustin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33074</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHP - Centre Hospitalier Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy - Hôpitaux de Brabois</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpitaux L'Archet 1 et 2</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Kennedy</name>
      <address>
        <city>Nîmes</city>
        <zip>30900</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHP - Groupe Hospitalier Pitié-Salpetrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Lyon - Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital PontChaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Belledonne</name>
      <address>
        <city>St Martin d'Héres</city>
        <zip>38400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Toulouse - Hôpital de Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours - Hôpital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2011</study_first_submitted>
  <study_first_submitted_qc>March 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>da Vinci Robot</keyword>
  <keyword>uterine prolapse</keyword>
  <keyword>vaginal prolapse</keyword>
  <keyword>sacrohysteropexy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

